Skip to content
Cryptos: 553Market Cap: $2.87T 1.3%24h Vol: $129.14BDominance: BTC 58.1% ETH 10.5%
Open Tradzy

Big move · Singapore stocks

iX Biopharma Ltd. (42C) rises 5.7% to SGD 0.56

Its biggest one-day rise in 5 weeks.

Published 12 October 2026 · Written from Tradzy's price and volume data

Close
SGD 0.56
On the day
+5.7%
Volume
0.9× average
vs 52-week high
−10.4%

iX Biopharma Ltd. closing prices

SGD 0.4000SGD 0.5000SGD 0.6000Jun '26Jul '26Jul '26Aug '26Sep '26Oct '26SGD 0.5600

The last 90 closes up to 12 October 2026. The live chart is on the 42C page.

What happened

iX Biopharma Ltd. (42C) closed at SGD 0.56 on 12 October 2026, up 5.7% from SGD 0.53 the session before.

It was 42C's biggest one-day rise in 5 weeks. It was the second higher close in a row. Over 5 sessions the price is up 0.9%, and over 20 sessions it is up 3.7%.

The close is 10.4% below the highest close of the past year (SGD 0.625 on 9 Sept 2026) and 591.4% above the lowest (SGD 0.081 on 21 Oct 2025).

Volume was close to its recent average.

Across the 26 SES stocks we track, 7 closed higher and 11 closed lower that day, with a median change of 0.00%. 42C's change was +5.7%.

This page reports what the price and volume data show. It does not say why the price moved.

The numbers

Previous closeSGD 0.5300
CloseSGD 0.5600
Change on the day+5.66%
Change over 5 sessions+0.90%
Change over 20 sessions+3.70%
Volume14.32 Million
Average volume, up to 20 sessions before15.99 Million
Volume against that average0.9 times
Highest close in the past yearSGD 0.6250 (9 Sept 2026)
Lowest close in the past yearSGD 0.0810 (21 Oct 2025)

The full chart and history are on iX Biopharma Ltd. (42C). More from this market: SES news today.

More SES moves on 12 October 2026

Want a plan for 42C? Open it in Tradzy: the Analyst Engine reads the chart and lays out an entry, a stop and targets, and you can practise the trade with paper money first.

Open Tradzy

Built from Tradzy's own price and volume data. It reports what the market did and does not say why. Nothing here is financial advice. See the disclaimer.